Diabetes and Mental Health

Diabetes Canada Clinical Practice Guidelines Expert Committee

doi:10.1016/j.jcjd.2017.10.031

Diabetes and Mental Health

Diabetes Canada Clinical Practice Guidelines Expert Committee

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

138 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	S130-S141
Publicación	Canadian Journal of Diabetes
Volumen	42
DOI	https://doi.org/10.1016/j.jcjd.2017.10.031
Estado	Published - abr. 2018

Nota bibliográfica

Funding Information:
Dr. Robinson reports personal fees from Janssen, Otsuka, Lundbeck, and Allergan, outside the submitted work. Dr. Coons has received honoraria from the Canadian Medical and Surgical Knowledge Translation Working Group. Dr. Vallis reports personal fees from Novo Nordisk, Valeant, Sanofi, Pfizer, CSL Behring, Merck, and Abbvie, outside the submitted work. Dr. Yale reports grants and personal fees from Eli Lilly Canada, Sanofi, Merck, AstraZeneca, Boehringer Ingelheim, Janssen, and Medtronic; personal fees from Novo Nordisk, Takeda, Abbott, and Bayer; and grants from Mylan. No other author has anything to disclose.

ASJC Scopus Subject Areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

PubMed: MeSH publication types

Journal Article

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/j.jcjd.2017.10.031

Otros archivos y enlaces

Citar esto

@article{9f34a347d3114d2f9c9d777d40ed823b,

title = "Diabetes and Mental Health",

author = "{Diabetes Canada Clinical Practice Guidelines Expert Committee} and Robinson, {David J.} and Michael Coons and Heidi Haensel and Michael Vallis and Yale, {Jean Fran{\c c}ois}",

note = "Funding Information: Dr. Robinson reports personal fees from Janssen, Otsuka, Lundbeck, and Allergan, outside the submitted work. Dr. Coons has received honoraria from the Canadian Medical and Surgical Knowledge Translation Working Group. Dr. Vallis reports personal fees from Novo Nordisk, Valeant, Sanofi, Pfizer, CSL Behring, Merck, and Abbvie, outside the submitted work. Dr. Yale reports grants and personal fees from Eli Lilly Canada, Sanofi, Merck, AstraZeneca, Boehringer Ingelheim, Janssen, and Medtronic; personal fees from Novo Nordisk, Takeda, Abbott, and Bayer; and grants from Mylan. No other author has anything to disclose.",

year = "2018",

month = apr,

doi = "10.1016/j.jcjd.2017.10.031",

language = "English",

volume = "42",

pages = "S130--S141",

journal = "Canadian Journal of Diabetes",

issn = "1499-2671",

publisher = "Canadian Diabetes Association",

}

TY - JOUR

T1 - Diabetes and Mental Health

AU - Diabetes Canada Clinical Practice Guidelines Expert Committee

AU - Robinson, David J.

AU - Coons, Michael

AU - Haensel, Heidi

AU - Vallis, Michael

AU - Yale, Jean François

N1 - Funding Information: Dr. Robinson reports personal fees from Janssen, Otsuka, Lundbeck, and Allergan, outside the submitted work. Dr. Coons has received honoraria from the Canadian Medical and Surgical Knowledge Translation Working Group. Dr. Vallis reports personal fees from Novo Nordisk, Valeant, Sanofi, Pfizer, CSL Behring, Merck, and Abbvie, outside the submitted work. Dr. Yale reports grants and personal fees from Eli Lilly Canada, Sanofi, Merck, AstraZeneca, Boehringer Ingelheim, Janssen, and Medtronic; personal fees from Novo Nordisk, Takeda, Abbott, and Bayer; and grants from Mylan. No other author has anything to disclose.

PY - 2018/4

Y1 - 2018/4

UR - http://www.scopus.com/inward/record.url?scp=85044766868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044766868&partnerID=8YFLogxK

U2 - 10.1016/j.jcjd.2017.10.031

DO - 10.1016/j.jcjd.2017.10.031

M3 - Article

C2 - 29650085

AN - SCOPUS:85044766868

SN - 1499-2671

VL - 42

SP - S130-S141

JO - Canadian Journal of Diabetes

JF - Canadian Journal of Diabetes

ER -